BML-259

CAT: 0804-HY-108348-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-108348-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BML-259 is a potent cyclin-dependent kinase 5 (Cdk5) inhibitor, with IC50s of 64 and 98 nM for Cdk5 and Cdk2, respectively[1].
CAS Number
[267654-00-2]
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bml-259.html
Concentration
10mM
Purity
99.12
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(NC1=NC=C(C(C)C)S1)CC2=CC=CC=C2
Molecular Formula
C14H16N2OS
Molecular Weight
260.35
Precautions
H315, H319, H335
References & Citations
[1]Kaźmierczak A, et al. A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5) . Neurochem Int. 2011;58 (2) :206-214.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-W025074-01BML-278
HY-133095-01BML-260
HY-114023BML-288
HY-19987-01BML-284
HY-13946-01BML-277
HY-169948BML-265
HY-15420-01BML-190
HY-19350-01BML-210
HY-114095-01BML-280
HY-113721BML-244

Alternative Products

CatalogName
M28107-01BML-259
MBS808135-01Bml 259
TBI1025-25MGBML-259, CDK5/p25 inhibitor
MBS131442BML-210, (BML210; BML 210)
MBS131522BML-284 (BML 284; BML284)
M18363-01BML-190
262826-01BML-286
MBS565614-01BML-284
MBS565494-01BML-267
MBS565675-01BML-260

Popular Products